Miyuki Azuma

Q: What Schools Are Affiliated With Miyuki Azuma

Miyuki Azuma is affiliated with the following schools: University of Tokyo, Augusta University, Institute of Science Tokyo, Juntendo University, Osaka University, Kyoto University

Miyuki Azuma's AcademicInfluence.com Rankings

Miyuki Azuma

Computer Science

#8460

World Rank

#8893

Historical Rank

Artificial Intelligence

#3770

World Rank

#3825

Historical Rank

Database

#5466

World Rank

#5670

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Miyuki Azuma's Degrees

PhD Computer Science University of Tokyo
Masters Artificial Intelligence Kyoto University
Bachelors Computer Science Kyoto University

Similar Degrees You Can Earn

Why Is Miyuki Azuma Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Miyuki Azuma's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

B70 antigen is a second ligand for CTLA-4 and CD28 (1993) (970)
Expression of Programmed Death 1 Ligands by Murine T Cells and APC1 (2002) (892)
Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2 (2012) (799)
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. (2007) (760)
The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice (2003) (754)
Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer (2005) (738)
B7-H1 Expression on Non-Small Cell Lung Cancer Cells and Its Relationship with Tumor-Infiltrating Lymphocytes and Their PD-1 Expression (2004) (718)
Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer (2007) (709)
The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro (1994) (673)
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal (2009) (641)
Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase (1994) (594)
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. (2011) (529)
CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. (1995) (517)
Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune Encephalomyelitis (2003) (509)
Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers (2007) (438)
CD28- T lymphocytes. Antigenic and functional properties. (1993) (420)
A critical role for the programmed death ligand 1 in fetomaternal tolerance (2005) (395)
CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes (1992) (374)
Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. (2009) (370)
B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells (1994) (365)
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway (2006) (313)
Functional expression of B7/BB1 on activated T lymphocytes (1993) (300)
Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. (2010) (264)
Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma. (2015) (256)
Costimulation via Glucocorticoid-Induced TNF Receptor in Both Conventional and CD25+ Regulatory CD4+ T Cells1 (2004) (253)
An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers. (2015) (222)
B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts1 (2006) (209)
Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). (1991) (198)
Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses (2008) (198)
Role of the Programmed Death-1 Pathway in Regulation of Alloimmune Responses In Vivo1 (2005) (193)
Differential binding properties of B7-H1 and B7-DC to programmed death-1. (2003) (188)
Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule (1995) (186)
Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. (1992) (175)
Blockade of B7-H1 Suppresses the Development of Chronic Intestinal Inflammation 1 (2003) (171)
BAFF/BLyS can potentiate B-cell selection with the B-cell coreceptor complex. (2004) (170)
Cooperative B7-1/2 (CD80/CD86) and B7-DC Costimulation of CD4+ T Cells Independent of the PD-1 Receptor (2003) (167)
Analysis of the Role of Negative T Cell Costimulatory Pathways in CD4 and CD8 T Cell-Mediated Alloimmune Responses In Vivo1 (2005) (165)
Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality. (2013) (161)
The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells. (2004) (159)
The Link between the PDL1 Costimulatory Pathway and Th17 in Fetomaternal Tolerance (2011) (150)
Cutting Edge: Programmed Death-1/Programmed Death Ligand 1 Interaction Regulates the Induction and Maintenance of Invariant NKT Cell Anergy1 (2008) (147)
A Link between PDL1 and T Regulatory Cells in Fetomaternal Tolerance1 (2007) (143)
Involvement of the Programmed Death-1/Programmed Death-1 Ligand Pathway in CD4+CD25+ Regulatory T-Cell Activity to Suppress Alloimmune Responses (2007) (142)
Blockade of B7-H1 on Macrophages Suppresses CD4+ T Cell Proliferation by Augmenting IFN-γ-Induced Nitric Oxide Production1 (2005) (142)
Blockade of B7-H1 (Programmed Death Ligand 1) Enhances Humoral Immunity by Positively Regulating the Generation of T Follicular Helper Cells (2011) (136)
Involvement of Inducible Costimulator-B7 Homologous Protein Costimulatory Pathway in Murine Lupus Nephritis 1 (2003) (133)
Preferential contribution of B7‐H1 to programmed death‐1‐mediated regulation of hapten‐specific allergic inflammatory responses (2003) (132)
Requirements for CD28-dependent T cell-mediated cytotoxicity. (1993) (132)
B7-DC Regulates Asthmatic Response by an IFN-γ-Dependent Mechanism1 (2004) (129)
Impaired CD4 and CD8 Effector Function and Decreased Memory T Cell Populations in ICOS-Deficient Patients (2009) (127)
Necessity of IgE antibodies and mast cells for manifestation of resistance against larval Haemaphysalis longicornis ticks in mice. (1990) (127)
Circadian Control of Chloroplast Transcription by a Nuclear-Encoded Timing Signal (2013) (122)
PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells1 (2009) (122)
The Novel Costimulatory Programmed Death Ligand 1/B7.1 Pathway Is Functional in Inhibiting Alloimmune Responses In Vivo (2011) (120)
Amelioration of Collagen-Induced Arthritis by Blockade of Inducible Costimulator-B7 Homologous Protein Costimulation1 (2002) (118)
Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma. (2006) (115)
Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model. (2009) (114)
Mechanisms of PDL1-mediated regulation of autoimmune diabetes. (2007) (108)
Differential Role of Programmed Death-Ligand 1 and Programmed Death-Ligand 2 in Regulating the Susceptibility and Chronic Progression of Experimental Autoimmune Encephalomyelitis1 (2006) (106)
VISTA expressed in tumour cells regulates T cell function (2018) (105)
PDL1 Is Required for Peripheral Transplantation Tolerance and Protection from Chronic Allograft Rejection1 (2007) (105)
Interactions between programmed death-1 and programmed death ligand-1 promote tolerance by blocking the T cell receptor-induced stop signal (2009) (101)
PD‐1/B7‐H1 Interaction Contribute to the Spontaneous Acceptance of Mouse Liver Allograft (2010) (100)
Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant. (1999) (99)
Serum levels of soluble Fas/APO‐1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases (1997) (97)
Preferential Involvement of Tim-3 in the Regulation of Hepatic CD8+ T Cells in Murine Acute Graft-versus-Host Disease1 (2006) (96)
The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity. (1996) (95)
Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7. (1998) (95)
Genetic Engineering of Group 2 σ Factor SigE Widely Activates Expressions of Sugar Catabolic Genes in Synechocystis Species PCC 6803* (2011) (93)
Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP 2 (2012) (92)
B7-H1 overexpression regulates epithelial-mesenchymal transition and accelerates carcinogenesis in skin. (2011) (90)
Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan: clinical and immunological findings. (2004) (90)
Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28. (1998) (89)
Critical Role of Donor Tissue Expression of Programmed Death Ligand-1 in Regulating Cardiac Allograft Rejection and Vasculopathy (2008) (88)
Blockade of the Interaction Between PD-1 and PD-L1 Accelerates Graft Arterial Disease in Cardiac Allografts (2004) (86)
Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation‐induced apoptosis (1996) (82)
Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells. (2008) (80)
Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells. (2006) (80)
Expression of membrane-bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells. (2004) (80)
Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma. (2016) (78)
Efficient virus transmission from dendritic cells to CD4+ T cells in response to antigen depends on close contact through adhesion molecules. (1997) (78)
B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism. (2004) (77)
Crucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4+Foxp3+ regulatory T cells in the establishment of oral tolerance. (2010) (76)
The presence of costimulatory molecules CD86 and CD28 in rheumatoid arthritis synovium. (1996) (74)
Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. (1999) (72)
Fundamental mechanisms of host immune responses to infection. (2006) (71)
Functional expression of costimulatory molecule CD86 on epithelial cells in the inflamed colonic mucosa. (1999) (71)
Expression of perforin and cytolytic potential of human peripheral blood lymphocyte subpopulations. (1992) (68)
Enterotoxin adjuvants have direct effects on T cells and antigen-presenting cells that result in either interleukin-4-dependent or -independent immune responses. (2000) (67)
The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role. (2004) (65)
Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. (2006) (64)
PD-1, but Not PD-L1, Expressed by Islet-Reactive CD4+ T Cells Suppresses Infiltration of the Pancreas During Type 1 Diabetes (2013) (64)
Tumour rejection by gene transfer of 4-1BB ligand into a CD80(+) murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells. (2000) (64)
Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjögren's syndrome. (1998) (61)
Th2 Cell-Intrinsic Hypo-Responsiveness Determines Susceptibility to Helminth Infection (2013) (61)
Ameliorating effect of anti-inducible costimulator monoclonal antibody in a murine model of chronic colitis. (2003) (59)
Programmed Death-1 Pathway in Host Tissues Ameliorates Th17/Th1-Mediated Experimental Chronic Graft-versus-Host Disease (2014) (59)
Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells. (1997) (59)
A response regulator Rre37 and an RNA polymerase sigma factor SigE represent two parallel pathways to activate sugar catabolism in a cyanobacterium Synechocystis sp. PCC 6803. (2011) (59)
Expression of tumour necrosis factor (TNF) ligand superfamily co‐stimulatory molecules CD30L, CD27L, OX40L, and 4‐1BBL in murine hearts with acute myocarditis caused by Coxsackievirus B3 (2001) (57)
Sugar catabolism regulated by light- and nitrogen-status in the cyanobacterium Synechocystis sp. PCC 6803. (2007) (57)
RANKL expression, function, and therapeutic targeting in multiple myeloma and chronic lymphocytic leukemia. (2013) (57)
Differential control of CD4+ T‐cell subsets by the PD‐1/PD‐L1 axis in a mouse model of allergic asthma (2015) (55)
Intrahepatic expression of the co‐stimulatory molecules programmed death‐1, and its ligands in autoimmune liver disease (2007) (53)
Studies on Murine IgE with Monoclonal Antibodies (1988) (52)
Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3. (2007) (51)
Regulation of murine IgE production in SJA/9 and nude mice. Potentiation of IgE production by recombinant interleukin 4. (1987) (50)
Adhesion of Plasmodium Falciparwn‐lnfected Erythroeytes to Human Cells and Seeretion of Cytokines (IL‐1‐β, IL‐1RA, IL‐6, IL‐8, IL‐10, TGFβ, TNFα, G‐CSF, GM‐CSF) (1995) (50)
Paracrine IL-33 Stimulation Enhances Lipopolysaccharide-Mediated Macrophage Activation (2011) (49)
Spontaneous production of various cytokines except IL‐4 from CD4+ T cells in the affected organs of sarcoidosis patients (1995) (49)
B7-DC induced by IL-13 works as a feedback regulator in the effector phase of allergic asthma. (2008) (48)
Blockade of CTLA-4 Signals Inhibits Th2-Mediated Murine Chronic Graft-Versus-Host Disease by an Enhanced Expansion of Regulatory CD8+ T Cells1 (2000) (48)
Transforming genes in human leukemia cells. (1985) (47)
Regulation of Trypanosoma cruzi-Induced Myocarditis by Programmed Death Cell Receptor 1 (2011) (47)
Preferential Blockade of CD8+ T Cell Responses by Administration of Anti-CD137 Ligand Monoclonal Antibody Results in Differential Effect on Development of Murine Acute and Chronic Graft-Versus-Host Diseases1 (2001) (47)
Characterization of rat CD80 and CD86 by molecular cloning and mAb. (1997) (46)
Role of the glucocorticoid-induced TNFR-related protein (GITR)-GITR ligand pathway in innate and adaptive immunity. (2010) (44)
Functional CD86 (B7‐2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis (1997) (43)
CD86 (B70/B7-2) on endothelial cells co-stimulates allogeneic CD4+ T cells. (1995) (43)
Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cells. (1995) (43)
Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection. (2001) (42)
Functional CD86 (B7-2/B70) on cultured human Langerhans cells. (1996) (42)
GITR ligand-mediated local expansion of regulatory T cells and immune privilege of corneal allografts. (2010) (42)
Increased prevalence of interleukin‐17–producing CD4+ tumor infiltrating lymphocytes in human oral squamous cell carcinoma (2011) (42)
Programmed death-1–programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen (2004) (41)
Enhancement of T‐cell‐mediated anti‐tumour immunity via the ectopically expressed glucocorticoid‐induced tumour necrosis factor receptor‐related receptor ligand (GITRL) on tumours (2009) (40)
Small interfering RNA against CD86 during allergen challenge blocks experimental allergic asthma (2014) (40)
GITR ligand-costimulation activates effector and regulatory functions of CD4+ T cells. (2008) (39)
Differential role of CD80 and CD86 molecules in the induction and the effector phases of allergic rhinitis in mice. (2001) (39)
The existence of CD11c+ sentinel and F4/80+ interstitial dendritic cells in dental pulp and their dynamics and functional properties. (2006) (39)
Immunoregulatory molecule B7-H1 (CD274) contributes to skin carcinogenesis. (2011) (38)
Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on murine acute myocarditis caused by coxsackievirus B3. (1998) (38)
Vaccine effect of granulocyte–macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity (1998) (37)
Expression of costimulatory molecule CD40 in murine heart with acute myocarditis and reduction of inflammation by treatment with anti-CD40L/B7-1 monoclonal antibodies. (1998) (37)
Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy. (1998) (36)
Role of costimulatory molecules in autoimmunity. (2000) (36)
Accessory cell function of airway epithelial cells. (2004) (36)
Keratinocyte-Associated B7-H1 Directly Regulates Cutaneous Effector CD8+ T Cell Responses (2010) (36)
Enhancement of effector CD8+ T‐cell function by tumour‐associated B7‐H3 and modulation of its counter‐receptor triggering receptor expressed on myeloid cell‐like transcript 2 at tumour sites (2010) (34)
Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice (2006) (34)
Effect of CD80 and CD86 blockade and anti‐interleukin‐12 treatment on mouse acute graftversus‐host disease (1996) (34)
Japanese subgingival microbiota in health vs disease and their roles in predicted functions associated with periodontitis (2019) (33)
Adhesion of Plasmodium falciparum-infected erythrocytes to human cells and secretion of cytokines (IL-1-beta, IL-1RA, IL-6, IL-8, IL-10, TGF beta, TNF alpha, G-CSF, GM-CSF. (1995) (33)
Expression of B7-H1 and B7-DC on the airway epithelium is enhanced by double-stranded RNA. (2005) (32)
Studies on murine IgE with monoclonal antibodies. I. Characterization of rat monoclonal anti-IgE antibodies and the use of these antibodies for determinations of serum IgE levels and for anaphylactic reactions. (1988) (31)
Process for immune defect and chromosomal translocation during early thymocyte development lacking ATM. (2012) (31)
Intact B7‐H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responses (2012) (31)
Identification of three distinct subsets of migrating dendritic cells from oral mucosa within the regional lymph nodes (2009) (30)
Protective and therapeutic immunity against leukemia induced by irradiated B7-1 (CD80)-transduced leukemic cells. (1997) (29)
Possible involvement of soluble B7-H4 in T cell-mediated inflammatory immune responses. (2009) (28)
The CD28-B7 Family of Co-signaling Molecules. (2019) (27)
Rapid development of murine AIDS is dependent of signals provided by CD54 and CD11a. (1995) (27)
Co-signal Molecules in T-Cell Activation : Historical Overview and Perspective. (2019) (27)
The deficiency of immunoregulatory receptor PD-1 causes mild osteopetrosis. (2004) (26)
Roles for TGF-β and Programmed Cell Death 1 Ligand 1 in Regulatory T Cell Expansion and Diabetes Suppression by Zymosan in Nonobese Diabetic Mice (2010) (25)
Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity. (1996) (25)
GM‐CSF and B7‐1 (CD80) co‐stimulatory signals co‐operate in the induction of effective anti‐tumor immunity in syngeneic mice (1997) (25)
Soluble Fas molecule in the serum of patients with systemic lupus erythematosus (1996) (25)
Receptor Activator for NF-κB Ligand in Acute Myeloid Leukemia: Expression, Function, and Modulation of NK Cell Immunosurveillance (2013) (25)
Stat6 activation and Th2 cell proliferation driven by CD28 signals (2000) (25)
The role of CD28 costimulation in the generation of cytotoxic T lymphocytes. (1995) (24)
Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice. (1996) (24)
Differential graft‐versus‐leukaemia effect by CD28 and CD40 co‐stimulatory blockade after graft‐versus‐host disease prophylaxis (2002) (24)
Interferon‐gamma differentially regulates CD80 (B7‐1) and CD86 (B7‐2/B70) expression on human Langerhans cells (1997) (24)
Expression of costimulatory CD80/CD86‐CD28/CD152 molecules in nasal mucosa of patients with perennial allergic rhinitis (2001) (23)
Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy (2018) (22)
Costimulatory effect of IL-12 on the activation of naive, memory CD4+ T cells, and Th1 clone. (1997) (22)
Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells (2000) (22)
Allergen‐specific immunotherapy alters the expression of B and T lymphocyte attenuator, a co‐inhibitory molecule, in allergic rhinitis (2008) (22)
The role of CTLA-4 in murine contact hypersensitivity. (2001) (21)
CD4 T-Cell Help Programs a Change in CD8 T-Cell Function Enabling Effective Long-Term Control of Murine Gammaherpesvirus 68: Role of PD-1-PD-L1 Interactions (2010) (21)
The Glucocorticoid-Induced TNF Receptor-Related Protein (GITR)-GITR Ligand Pathway Acts As a Mediator of Cutaneous Dendritic Cell Migration and Promotes T Cell-Mediated Acquired Immunity1 (2009) (20)
Antigen‐specific B cells are required for the secondary response of T cells but not for their priming (1996) (20)
Th2 Responses to Helminth Parasites Can Be Therapeutically Enhanced by, but Are Not Dependent upon, GITR–GITR Ligand Costimulation In Vivo (2011) (20)
Expression of IFN-gamma before and after treatment of oral lichen planus with 0.1% fluocinolone acetonide in orabase. (2009) (20)
Augmentation of CTLA-4 expression by wortmannin: involvement of lysosomal sorting properties of CTLA-4. (1999) (20)
Expression of ductal Fas antigen in sialoadenitis of Sjögren's syndrome. (1995) (19)
Blockade of PD-1 Attenuated Post-Sepsis Aspergillosis via The Activation Of IFN-γ and The Dampening of IL-10. (2020) (19)
Critical role of Fas/Fas ligand interaction in CD28‐independent pathway of allogeneic murine hepatocyte rejection (1997) (19)
Expression of tumour necrosis factor (TNF) receptor/ligand superfamily co‐stimulatory molecules CD40, CD30L, CD27L, and OX40L in murine hearts with chronic ongoing myocarditis caused by Coxsackie virus B3 (1999) (18)
CD8+ T cells and not CD4+ T cells are hyporesponsive to CD28‐ and CD40L‐mediated activation in HIV‐infected subjects (1997) (18)
Endogenous IL-33 exerts CD8+ T cell antitumor responses overcoming pro-tumor effects by regulatory T cells in a colon carcinoma model. (2019) (17)
CD28 co-stimulation of T-cell-mediated cytotoxicity. (1992) (17)
Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice. (2009) (17)
PD‐L1 blockade overrides Salmonella typhimurium‐mediated diabetes prevention in NOD mice: No role for Tregs (2011) (16)
A novel beta 4, alpha 6 integrin-associated epithelial cell antigen involved in natural killer cell and antigen-specific cytotoxic T lymphocyte cytotoxicity (1991) (16)
HTLV‐I‐infected T cells activate autologous CD4+ T cells susceptible to HTLV‐I infection in a co‐stimulatory molecule‐dependent fashion (1997) (16)
In Vivo Function of Immune Inhibitory Molecule B7‐H4 in Alloimmune Responses (2010) (16)
Expression of tumor necrosis factor ligand superfamily costimulatory molecules CD27L, CD30L, OX40L and 4-1BBL in the heart of patients with acute myocarditis and dilated cardiomyopathy. (2002) (16)
Anti‐CD3 treatment up‐regulates programmed cell death protein‐1 expression on activated effector T cells and severely impairs their inflammatory capacity (2017) (16)
Fas/Fas ligand-mediated apoptosis of murine Langerhans cells. (2000) (16)
Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma (2018) (15)
Bacillus Calmette-Guérin Induces PD-L1 Expression on Antigen-Presenting Cells via Autocrine and Paracrine Interleukin-STAT3 Circuits (2019) (15)
B7-1 mediated costimulation regulates pancreatic autoimmunity. (2007) (15)
Stat6 activation and Th2 cell differentiation [correction of proliferation] driven by CD28 [correction of CD28 signals]. (2000) (15)
Autoantigen-Specific CD4+CD28low T Cell Subset Prevents Autoimmune Exocrinopathy in Murine Sjögren’s Syndrome1 (2000) (15)
Contributions of Interleukin‐33 and TSLP in a papain‐soaked contact lens‐induced mouse conjunctival inflammation model (2017) (15)
Topical application of siRNA targeting cutaneous dendritic cells in allergic skin disease. (2010) (15)
Repeated antigen painting and sublingual immunotherapy in mice convert sublingual dendritic cell subsets. (2014) (15)
Correlation of Circulating CD64+/CD163+ Monocyte Ratio and stroma/peri-tumoral CD163+ Monocyte Density with Human Papillomavirus Infected Cervical Lesion Severity (2017) (14)
B7‐1 synergizes with interleukin‐12 in interleukin‐2 receptor α expression by mouse T helper 1 clones (1996) (14)
Differential expression of co-signal molecules and migratory properties in four distinct subsets of migratory dendritic cells from the oral mucosa. (2011) (14)
The immune checkpoint molecule VISTA regulates allergen-specific Th2-mediated immune responses (2018) (14)
Dental Pulp Dendritic Cells Migrate to Regional Lymph Nodes (2014) (14)
Rapid induction of CD95 ligand and CD4+ T cell‐mediated apoptosis by CD137 (4–1BB) costimulation (2001) (13)
Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environment (2017) (13)
T-Cell Development Failure At β-Selection Checkpoint and TCRα/δ Locus Break Formation Associated with Chromosome 14 Translocation in Ataxia-Telangiectagia Mutated Deficient Mice (2011) (13)
Functional Expression of B7/BB1 on Activated (1993) (12)
Unique B7-H1 expression on masticatory mucosae in the oral cavity and trans-coinhibition by B7-H1-expressing keratinocytes regulating CD4+ T cell-mediated mucosal tissue inflammation (2016) (12)
Expression and Regulation of Human CD275 on Endothelial Cells in Healthy and Inflamed Mucosal Tissues (2006) (12)
Subcutaneous injections of a TNF-alpha antagonistic peptide inhibit both inflammation and bone resorption in collagen-induced murine arthritis. (2005) (11)
PI3K‐Akt pathway enhances the differentiation of interleukin‐27‐induced type 1 regulatory T cells (2017) (11)
A Response Regulator Rre 37 and an RNA Polymerase Sigma Factor SigE Represent Two Parallel Pathways to Activate Sugar Catabolism in a Cyanobacterium Synechocystis sp . PCC 6803 (2011) (11)
Inducible-costimulator-mediated suppression of human immunodeficiency virus type 1 replication in CD4(+) T lymphocytes. (2004) (11)
Essential role of B7-H1 in double-stranded RNA-induced augmentation of an asthma phenotype in mice. (2011) (10)
Marked Suppression of T Cells by a Benzothiophene Derivative in Patients with Human T-Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis (1999) (10)
Co-expression of Tim-3 and PD-1 Identifies a CD8+T-Cell Exhaustion Phenotype in Mice with Disseminated Acute Myelogenous Leukemia (2011) (10)
TGF-β-induced phosphorylation of Akt and Foxo transcription factors negatively regulates induced regulatory T cell differentiation. (2016) (10)
HPV16 E2 protein promotes innate immunity by modulating immunosuppressive status. (2014) (10)
Human B7-H3 binds to Triggering receptor expressed on myeloid cells-like transcript 2 (TLT-2) and enhances T cell responses (2012) (10)
Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2. (1998) (10)
Effects of in vivo administration of anti‐B7‐1/B7‐2 monoclonal antibodies on the survival of mice with chronic ongoing myocarditis caused by Coxsackievirus B3 (1999) (10)
Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockade. (2019) (9)
Deep sequencing reveals specific bacterial signatures in the subgingival microbiota of healthy subjects (2019) (8)
Antibodies against B7-DC with differential binding properties exert opposite effects. (2012) (8)
Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade (2022) (8)
VISTA Is Crucial for Corneal Allograft Survival and Maintenance of Immune Privilege. (2019) (8)
Silencing of PD-L2/B7-DC by Topical Application of Small Interfering RNA Inhibits Elicitation of Contact Hypersensitivity. (2019) (7)
Suppression of humoral immunity by monoclonal antibody to CD79b, an invariant component of antigen receptors on B lymphocytes. (1996) (7)
Multipotency of CD11bhighGr-1+ immature myeloid cells accumulating in oral squamous cell carcinoma-bearing mice. (2007) (7)
Co-signal Molecules in T Cell Activation: Immune Regulation in Health and Disease (2019) (7)
Peripheral Tolerance and the Qualitative Characteristics of Autoreactive T Cell Clones in Primary Biliary Cirrhosis1 (2007) (6)
ANALYSIS OF THE ROLE OF NEGATIVE T CELL COSTIMULATORY PATHWAYS IN CD4 AND CD8 MEDIATED ALLOIMMUNE RESPONSES IN VIVO (2004) (6)
Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model (2020) (6)
Lacking CD 28 Graft-Versus-Host Disease Induced by Allogeneic CTLA 4-B 7 Pathways in Murine Acute Involvement of CD 40 Ligand-CD 40 and (1998) (6)
Replication‐deficient adenovirus‐mediated transfer of B7‐1 (CD80) cDNA induces anti‐tumour immunity in isolated human lung cancer (2001) (6)
Site-specific regulation of oral mucosa-recruiting CD8+ T cells in a mouse contact allergy model. (2017) (6)
[Costimulatory molecules in autoimmunity: role of CD28/CTLA4-CD80/CD86]. (1997) (5)
Overexpression of PD‐L1 in gingival basal keratinocytes reduces periodontal inflammation in a ligature‐induced periodontitis model (2021) (5)
Roles for TGF-b and Programmed Cell Death 1 Ligand 1 in Regulatory T Cell Expansion and Diabetes Suppression by Zymosan in Nonobese Diabetic Mice (2010) (5)
Immune Checkpoint Molecule, VISTA Regulates T-Cell-Mediated Skin Inflammatory Responses. (2017) (5)
Effector T cell function rather than survival determines extent and duration of hepatitis in mice. (2016) (5)
Corrigendum to 'Mechanisms of PDL1-mediated regulation of autoimmune diabetes' [Clin. Immunol. 125 (2007) 16-25] (2014) (5)
Programmed death 1 and its ligands do not limit experimental foreign antigen‐induced immune complex glomerulonephritis (2015) (4)
Tolerogenic properties of CD206+ macrophages appeared in the sublingual mucosa after repeated antigen-painting. (2020) (4)
Differential role of programmed death-1 ligand and programmed death-2 ligand in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis (2006) (4)
Program death-1 (PD-1) signaling and regulatory T cells (Tregs) collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes (CTLs) in advanced acute myeloid leukemia (AML) Running title: PD-1 blockade and adoptive CTL therapy for AML (2010) (4)
PD-L2 suppresses T cell signaling via coinhibitory microcluster formation and SHP2 phosphatase recruitment (2021) (4)
Evidence of cell-mediated cardiac myocyte injury involved in the heart failure of a patient with progressive systemic sclerosis. (1999) (4)
Involvement of Fas and Fas ligand interaction in allogeneic hepatocyte rejection in the spleen. (1997) (3)
Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer (2020) (3)
CD8+ cells and not CD4+ T cells are hyporesponsive to CD28- and CD40L-mediated activation in HIV-infected subjects. (1997) (3)
Inflammation Development of Chronic Intestinal Blockade of B 7-H 1 Suppresses the Chen and Mamoru (2003) (3)
Biological properties of fucoidans differing in molecular weight and composition: effects on lymphocyte proliferation and immunological function (2005) (3)
Polymorphonuclear Myeloid-Derived Cells That Contribute to the Immune Paralysis Are Generated in the Early Phase of Sepsis via PD-1/PD-L1 Pathway (2021) (2)
The Programmed Death-1 (pd-1) Pathway Regulates Peripheral T Cell Tolerance During Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice (2007) (2)
The extent and duration of acute hepatitis in mice is dominated by the function rather than by the survival of effector CD 8 T cells (2016) (2)
Orthotopic tongue squamous cell carcinoma (SCC) model exhibiting a different tumor-infiltrating T-cell status with margin-restricted CD8+ T cells and regulatory T cell-dominance, compared to skin SCC. (2020) (2)
VSIG4/CRIg directly regulates early CD8+ T cell activation through its counter-receptor in a narrow window. (2022) (2)
Perforin-positive leukemic cell infiltration in the aortic tissue of a patient with T-cell prolymphocytic leukemia. (1996) (2)
Blockade of PD-L1, but not PD-L2 suppresses the development of chronic intestinal inflammation (2003) (1)
Carcinoma of the buccal mucosa: A clinical review of fourty-three cases. (1990) (1)
Abstract 563: Combined treatment with PD-L1 blockade and a TLR7/8 agonist dramatically enhances antitumor immunity (2016) (1)
Studies on IL-2 activated killer cells in oral cancer patients (1988) (1)
Clinico-statistical analysis of maxillary neoplasms (1990) (1)
Perforin-positive leukemic cell infiltration in the heart of a patient with T-cell prolymphocytic leukemia. (1995) (1)
Phenotype in Mice with Disseminated Acute Myelogenous Leukemia Running title: PD-1+Tim-3+ CD8+T-cells induced by AML are dysfunctional (2011) (1)
Murine Lupus Nephritis Homologous Protein Costimulatory Pathway Involvement of Inducible Costimulator-B 7 Miyuki (2003) (1)
RANKL Expressed by Acute Myeloid Leukemia Cells Impairs NK Cell-Mediated Immune Surveillance (2010) (1)
Hapten sensitization to vaginal mucosa induces less recruitment of dendritic cells accompanying TGF‐β‐expressing CD206+ cells compared with skin (2022) (1)
Human B 7-H 3 binds to Triggering receptor expressed on myeloid cells-like transcript 2 ( TLT-2 ) and enhances T cell responses (2013) (1)
Expression of TLT-2 in Corneal Tissue and Macrophages after Corneal Transplantation and Association With Immune Privilege of Corneal Allografts (2011) (1)
Expression and Immunomodulatory Function of RANKL in Leukemia (2011) (1)
Lysis of fresh autologous tumor cells by interleukin 2 activated peripheral blood lymphocytes in patients with oral cancer (1989) (1)
Autoantigen-Specific CD4CD28 T Cell Subset Prevents Autoimmune Exocrinopathy in Murine Sjögren’s Syndrome (2000) (1)
Clinical significance and therapeutic potential of PD-L/PD-1 pathway in human pancreatic cancer (2006) (1)
Role of the programmed death‐1 (PD‐1) pathway in glycolipid‐induced iNKT cell anergy (2008) (1)
Genetic engineering of the group 2 sigma factor SigE widely activates the expressions of sugar catabolic genes in Synechocystis sp. PCC 6803 (2011) (1)
Regulation of Alloimmune Responses In Vivo Role of the Programmed Death-1 Pathway in Turka and (2005) (1)
Effects of anti-VISTA mAb and its combination therapy in antitumor immunity (TUM2P.1035) (2015) (1)
Application of immune adherence hemagglutination test in the screening of blood donors carrying a high titer antibody to varicella-zoster virus. (1986) (1)
Clinicopathological study on the cervical lymph node metastasis of maxillary carcinoma (1990) (1)
Functional Significance of PD-1 expression on aging T cells (85.4) (2007) (1)
Functions of the PD-1: PD-L1 costimulatory pathway in physiologic regulation of alloimmune responses in vivo (2003) (0)
Protective and therapeutic immunity against leukemia induced by irradiated B7-1 (CD80)-transduced leukemic cells. (1997) (0)
The role of PD-1/PD-L and B7/CD28 pathways in modulating anti-islet immune responses (B94) (2007) (0)
[Identification of 2 types of dendritic cells present in the dental pulp]. (2006) (0)
Production-Induced Nitric Oxide γ Augmenting IFN-T Cell Proliferation by + Suppresses CD 4 Blockade of B 7-H 1 on Macrophages (2005) (0)
Correction (1976) (0)
OJ-059 Roles of Programmed death (PD)-1/PD-1 Ligands Pathway in the Development of Murine Acute Myocarditis Caused by Coxsackievirus B3(Myocarditis, Basic/Clinical (M) : OJ7)(Oral Presentation (Japanese)) (2004) (0)
A Fc-Engineered RANK-Fc Fusion Protein Neutralizes Soluble RANK Ligand and Targets Malignant Hematopoietic Cells for NK Cell Reactivity. (2009) (0)
Mechanisms of V-domain Ig suppressor of T cell activation (VISTA)-mediated acceptance of corneal allografts (2015) (0)
Different anti-B7-DC monoclonal antibodies show differential functions in immune responses (88.20) (2007) (0)
Involvement of GITRL-GITR costimulatory pathway in T cell-mediated immune responses in vivo (88.23) (2007) (0)
Erratum: (The Journal of Experimemal Medicine (July 7, 2003) 198:1 (71-78)) (2003) (0)
VISTA expressed in tumour cells regulates T cell function (2018) (0)
Costimulation (PP-102) (2010) (0)
Role of Glucocorticoid-Induced TNF Receptor Ligand in Immune Privilege of Corneal Allografts (2007) (0)
Abstract: Head and neck cancers that have evidence of involvement of fixed regional lymph nodes metastasis had been defined as N3 by previous criteria of UICC in 1978. Thirty-nine (2011) (0)
Functional Role of CD80/86 and CTLA-4 in Interaction between T Cells and Antigen Presenting Cells on Contact Hypersensitivity (1997) (0)
GITRL-mediated costimulation in CD25−conventional and CD25+ regulatory CD4 T cells (88.16) (2007) (0)
Studies on the Management of Patients with Xerostomia : Clinical Classification and the Caries Susceptibility of Patients with Xerostomia (2002) (0)
Roles of Co-Stimulatory Molecules in the Development of Murine Allergic Conjunctivitis (2007) (0)
Costimulation (WS-102) Chairpersons: Miyuki Azuma, Tania Watts (2010) (0)
B7-H3 co-stimulates T-cell immune responses via the B7-H3 receptor ligation (88.21) (2007) (0)
Homologous Protein Costimulation by Blockade of Inducible Costimulator-B7 Amelioration of Collagen-Induced Arthritis (2002) (0)
Reviewers (2010) (0)
Small Interfering RNA Against CD86 Attenuates Allergic Airway Inflammation (2012) (0)
The Tissue Distribution o f the B7-2 Cost imulator in Mice: Abundant Express ion on Dendri t ic Cells In Situ and D u r i n g Maturat ion In Vitro (2003) (0)
Antitumor Effect of CD40 Ligand: Elicitation (1998) (0)
V-domain Ig Suppressor of T Cell Activation (VISTA) is Necessary for Corneal Allograft Survival (2013) (0)
ICOS-Deficient Patients inand Decreased Memory T Cell Populations Impaired CD 4 and CD 8 Effector Function Tomohiro (2009) (0)
Costimulation In Vivo GITR Ligand − Dependent upon, GITR Therapeutically Enhanced by, but Are Not Th2 Responses to Helminth Parasites Can Be (2011) (0)
myeloid cells accumulating in oral squamous cell carcinoma-bearing mice (2007) (0)
PD-L2 suppresses T cell signaling via coinhibitory microcluster formation and SHP2 phosphatase recruitment (2021) (0)
Preparative and Clinical Studies of Immunogene Therapy Using Autologous GM-CSF Transduced Tumor Vaccines for Stage IV Renal Cell Cancer (1999) (0)
Role of ICOS/B7RP-1 Pathway in Immune Privilege of Corneal Allografts (2010) (0)
[New strategy for immunity regulation]. (1997) (0)
B7–H1–Mediated Protection of Corneal Endothelial Cells From Killing by Allo–Reactive T Cells in vitro (2006) (0)
in Primary Biliary Cirrhosis Characteristics of Autoreactive T Cell Clones Peripheral Tolerance and the Qualitative (2007) (0)
A clinico-statistical study of maxillary gingival carcinomas. (1990) (0)
Blockade of B7-H1 on Macrophages (2005) (0)
S17.2 Manipulation of positive and negativecostimulation in cancer immunotherapy (2005) (0)
TNF Receptor in Both Conventional and Costimulation via Glucocorticoid-Induced (2013) (0)
Cells in Fetomaternal Tolerance A Link between PDL1 and T Regulatory (0)
Targeting RANKL for Immunotherapy of Multiple Myeloma (2011) (0)
The expression of Co-stimulatory molecules B7h and B7-H1 on colonic epithelial cells and their functional role in T cell activation (2003) (0)
PD–1 and PD ligand are necessary for corneal allograft survival (2004) (0)
The Effect of Recombinant CD80-Adenovirus and Interleukin-12 on Generation of Cytotoxic T Lymphocytes Against Autologous Tumour in Patients with Oral Squamous Cell Carcinoma (2002) (0)
Role of B7-H3/TLT-2 pathway in immune privilege of corneal allografts (2017) (0)
PE-179 The Interaction between Programmed-Death-1 (PD-1) and its Ligands (PD-L1) Regulates Acute Rejection and Graft Arterial Disease (GAD) in Cardiac Allografts(Infection/Inflammation/Immunity 2 (H) : PE31)(Poster Session (English)) (2004) (0)
Role of V-domain Ig suppressor of T cell activation (VISTA) in Anterior Chamber Associated Immune Deviation (2016) (0)
Positively Regulating the Generation of T Ligand 1) Enhances Humoral Immunity by Blockade of B7-H1 (Programmed Death (2011) (0)
Successful inhibition in contact hypersensitivity by topical painting of CD86 siRNA oligo (37.14) (2007) (0)
THE REQUIREMENT OF THE B7-H1 FOR SPONTANEOUS ACCEPTANCE AFTER MOUSE LIVER ALLOGRAFTING: 730 (2008) (0)
Induction of NK Cell Reactivity Against AML Cells by Fc-Engineered RANK-Ig Fusion Proteins. (2012) (0)
Clinical significance and therapeutic potential of targeting B7-H3 in pancreatic cancer (2008) (0)
Japanese subgingival microbiota in health vs disease and their roles in predicted functions associated with periodontitis (2019) (0)
Inhibiting Alloimmune Responses In Vivo Ligand 1/B7.1 Pathway Is Functional in The Novel Costimulatory Programmed Death (2011) (0)
Tissue concentration and clinical efficacy of Imipenem/Cilastatin sodium in the field of oral surgery (1989) (0)
Dual functions of PD-1 in CD4+ T cell responses by sublingual mucosa-mediated antigen application (P3210) (2013) (0)
Room 501 A-C, Los Angeles Convention Center Epidemiology 11 Inflammation, Immunity, and Novel Pathways (2007) (0)
312 Specificity of nasal γδ T cells in perennial allergic rhinitics (1998) (0)
A case of one-stage reconstruction with the free rectus abdominis myocutaneous flap after resection of oral cancer (1990) (0)
Molecules in Systemic Autoimmune Diseases Autoantibodies to T Cell Costimulatory (1999) (0)
Correlation Between Proportion of Splenic Foxp3+CD8+T Regulatory Cells and Corneal Allograft Survival (2011) (0)
A clinical review of previous N3 cases (criteria by UICC 1978) in oral cancers (1991) (0)
Effects of sublingual immunotherapy on a murine model of Japanese cedar pollinosis (P4198) (2013) (0)
Clinical Significance andTherapeutic Potential of the Programmed Death-1Ligand/Programmed Death-1Pathway in Human Pancreatic Cancer (2007) (0)
Su.26. PDL1 Regulates Autoimmunity By Limiting Expansion of Autoreactive Th1 Cells and Mediates Resistance to Diabetes in Nod Mice (2006) (0)
thymocyte development lacking ATM Process for immune defect and chromosomal translocation during early (2012) (0)
Overexpression of B7-H1 on epidermal keratinocytes promotes squamous cell carcinoma formation. (87.28) (2010) (0)
Effect of fas and fas ligand interaction on allogenetically transplanted hepatocytes into the spleen (1996) (0)
Cornea–Associated B7–H1 Promotes T–Cell Apoptosis as a Potential Mechanism of Immune Privilege of Corneal Allografts (2005) (0)
Research data supporting publication - title to be confirmed. (2016) (0)
Deep sequencing reveals specific bacterial signatures in the subgingival microbiota of healthy subjects (2019) (0)
DiseaseExperimental Chronic Graft-versus-Host Tissues Ameliorates Th17/Th1-Mediated Programmed Death-1 Pathway in Host (2014) (0)
Tumour rejection by gene transfer of 4‐1BB ligand into a CD80+ murine squamous cell carcinoma and the requirements of co‐stimulatory molecules on tumour and host cells (2000) (0)
In vivo distribution of adoptively transferred anti-CD3 monoclonal antibody and interleukin-2 activated autologous lymphocytes (LAK) in patients with oral cancer (1991) (0)
Rhabdomyosarcoma of the maxillary sinus: report of a case (1990) (0)
Bacillus Calmette-Guérin Induces PD-L1 Expression on Antigen-Presenting Cells via Autocrine and Paracrine Interleukin-STAT3 Circuits (2019) (0)
472 Nasal γδ- T cells in perennial allergic rhinitics express the CD40L and induce IgE synthesis (1996) (0)
of Local and Systemic Antitumor Responses Antitumor Effect of CD40 Ligand: Elicitation (2013) (0)
T cell-dependent and -independent regulatory roles of a new inhibitory molecule VISTA (APP3P.115) (2015) (0)
Host Tissue PD-1 Pathway Contribute To Murine Chronic Graft-Versus-Host Disease Via Th1+Th17+ Cells (2013) (0)
Significant therapeutic efficacy of blocking T cell negative regulatory pathway in vivo (2006) (0)
Cytokine profile of γδ T cells in perennial allergic rhinitis and chronic infectious rhinitis (1996) (0)
The control of immune response against Trypanosoma cruzi by PD-1 inhibitory co-receptor (2009) (0)
Mucosal immunology of the upper airway : Reassessing the role of mast cells and T cells in the pathogenesis of allergic rhinitis (1998) (0)
Abstract 3117: CD80 can be the marker of chronic myeloid leukemia stem cells and regulated by BCR-ABL signaling (2021) (0)
[Manipulation of costimulatory pathways in autoimmune disease]. (1997) (0)
Fc-Engineered RANK-Fc Fusion Proteins for Neutralization of Soluble RANKL and Induction of Antibody-Dependent Cellular Cytotoxicity (ADCC) Against Multiple Myeloma (2010) (0)
209 Functional expression of fas antigen(CD95) on murine Langerhans cells (1997) (0)
A Novel B4,ce6 htegrin-associated Epithelial Cell Antigen Involved in Natural Killer Cell and Antigen-specific Cytotoxic T Lymphocyte Cytotoxicity (2003) (0)
Role of B7-H3/TLT-2 Pathway on Corneal Allograft Survival (2010) (0)
The Blockade of Interaction between Programmed Death 1 (PD-1) and Its Ligands (PD-L1) Enhances Acute Rejection in Murine Cardiac Allografts (2003) (0)
Exchange Coupling Constants in Spin Ladders (1998) (0)
[T cell costimulation and diseases]. (2000) (0)
Expansion of Regulatory CD 8 Graft-Versus-Host Disease by an Enhanced Th 2-Mediated Murine Chronic Blockade of CTLA-4 Signals Inhibits (1999) (0)
AntiCD3 treatment upregulates PD1 expression on activated effector T cells and severely impairs their inflammatory capacity (2017) (0)
The Effects of Radiation on the cytotoxicity for NK and LAK Activity and the Proliferative Response to IL-2 of the Lymphokine-Activated Killer (LAK) Cells. (1991) (0)
Acute and Chronic Graft-Versus-Host Differential Effect on Development of Murine Ligand Monoclonal Antibody Results in Responses by Administration of Anti-CD 137 T Cell + Preferential Blockade of CD 8 and Miyuki (2001) (0)
GITR-Ligand-Dependent Local Expansion of Regulatory T Cells as a Mechanism of Immune Privilege for Corneal Allografts (2008) (0)
TolerancePathway and Th17 in Fetomaternal The Link between the PDL1 Costimulatory (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Miyuki Azuma?

Miyuki Azuma is affiliated with the following schools:

Miyuki Azuma's Academic­Influence.com Rankings

Miyuki Azuma's Degrees

Similar Degrees You Can Earn

Why Is Miyuki Azuma Influential?

Miyuki Azuma's Published Works

Published Works

What Schools Are Affiliated With Miyuki Azuma?

Miyuki Azuma's AcademicInfluence.com Rankings